FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Discover Magazine35m
FDA Approves Opioid Alternative for Pain Relief That Is Non-Addictive
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
Hosted on MSN56m
New FDA-Approved Painkiller Is a Safer Alternative to Opioids
Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...
Historic FDA approval marks first nonopioid breakthrough since Clinton era
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
The Globe and Mail13m
Stocks Climb on Apple Earnings Results and Benign US Inflation News
Vertex Pharmaceuticals (VRTX) is up more than +4% after receiving FDA approval for its non-opioid analgesic Journavx to treat moderate-to-severe acute pain in adults. LPL Financial Holdings (LPLA) is ...
WRTA seeing more security issues since bussing Youngstown students, working on solutions
Sen. Angela Alsobrooks (D-Md.) on Thursday grilled Department of Health and Human Services secretary nominee Robert F. Kennedy Jr. on his history of claiming Black Americans have a better immune ...